Extraction protocol and mass spectrometry method for quantification of doxorubicin released locally from prodrugs in tumor tissue. (18th June 2013)

• Record Type: Journal Article
• Authors: Ibsen, Stuart; Su, Yongxuan; Norton, John; Zahavy, Eran; Hayashi, Tomoko; Adams, Stephen; Wrasidlo, Wolf; Esener, Sadik
• Is Part Of: Journal of mass spectrometry. Volume 48:Number 7(2013:Jul.)
• Page Start: 768
• Page End: 773
• Publication Date: 2013-06-18
• Subjects: Mass spectrometry -- Periodicals; 543.65
• DOI: 10.1002/jms.3221
• Languages: English
• ISSNs: 1076-5174

Abstract

<abstract abstract-type="main"> <title> <x xml:space="preserve">Abstract</x> </title> <p>The localized conversion of inactive doxorubicin prodrug chemotherapeutics to pharmacalogically active forms is difficult to quantify in mouse tumor models because it occurs only in small regions of tissue. The tumor tissue extraction protocol and LC–MS/MS analysis method described here were optimized to obtain a detection limit of 7.8 pg for the activated doxorubicin and 0.36 ng for the doxorubicin prodrug. This method can be useful for determining the biodistribution and activation efficiency for many different doxorubicin prodrugs. It can also be used for quantification of doxorubicin from tumor models that have poor vascularization resulting in low tissue accumulation. Copyright © 2013 John Wiley &amp; Sons, Ltd.</p> </abstract>